Kore Private Wealth’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$361K Hold
7,130
0.07% 162
2022
Q2
$383K Sell
7,130
-1,675
-19% -$92K 0.06% 186
2022
Q1
$509K Buy
8,805
+1,600
+22% +$89.3K 0.06% 172
2021
Q4
$433K Sell
7,205
-25,490
-78% -$1.46M 0.05% 190
2021
Q3
$1.8M Buy
32,695
+2,170
+7% +$124K 0.19% 93
2021
Q2
$1.67M Buy
30,525
+6,370
+26% +$337K 0.19% 96
2021
Q1
$1.22M Buy
24,155
+19,155
+383% +$963K 0.16% 102
2020
Q4
$246K Sell
5,000
-1,455
-23% -$68.7K 0.04% 273
2020
Q3
$293K Sell
6,455
-2,510
-28% -$114K 0.06% 196
2020
Q2
$386K Buy
8,965
+2,800
+45% +$118K 0.08% 152
2020
Q1
$232K Buy
6,165
+5,165
+517% +$212K 0.06% 192
2019
Q4
$43K Buy
+1,000
New +$40.4K 0.01% 504
2019
Q2
Sell
-250
Closed -$10K 522
2019
Q1
$10K Sell
250
-9,505
-97% -$361K ﹤0.01% 626
2018
Q4
$356K Buy
+9,755
New +$374K 0.1% 143

Other funds holding IYH

Kore Private Wealth's IYH Position: Q3 2022 in Review

Kore Private Wealth held its iShares US Healthcare ETF (IYH) position steady in Q3 2022 at 7,130 shares worth $361K. The position accounts for 0.07% of the portfolio, ranked #162.

Kore Private Wealth first reported a position in IYH in Q4 2018 and has held it in 14 quarters since. The position peaked at $1.8M in Q3 2021. 426 funds tracked by Wall St. Rank hold IYH as of Q3 2022.

  • Kore Private Wealth held 7,130 shares of iShares US Healthcare ETF worth $361K as of Q3 2022.
  • Kore Private Wealth left its iShares US Healthcare ETF share count unchanged in Q3 2022.
  • iShares US Healthcare ETF made up 0.07% of Kore Private Wealth's portfolio in Q3 2022, its #162 holding.
  • Kore Private Wealth first reported a position in iShares US Healthcare ETF in Q4 2018 and has held it in 14 quarters since.
  • Kore Private Wealth's iShares US Healthcare ETF position peaked at $1.8M in Q3 2021.
  • 426 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.